-5%
Mabthera 500mg/50ml Solution for Infusion is an anticancer medicine that is used for the treatment of blood cancers.
Rituximab:
- Monoclonal antibody
- Targeted therapy for cancer treatment
- Chronic lymphocytic leukemia and certain types of non-Hodgkin’s lymphoma
- Given through an intravenous (IV) infusion
- Approximately 6 hours, with the possibility of reducing the time in subsequent administrations.
- Individualized by the doctor based on the patient’s health, age, weight, cancer severity, and body response.
- Information is based on the salt content of the medicine; individual uses and effects may vary.
- Consultation with an oncologist is advisable before using this medicine.
